Chemical investigation of a Chinese collection of a marine-derived fungus, Fusarium sp., led to the characterization of beauvericin K, a new analogue of beauvericin. The structure of the new compound was elucidated by detailed spectroscopic analysis, including 1D and 2D NMR methods, and HRMS. Beauvericin K showed significant activity against the yeast Candida albicans with an IC 50 value of 6.25 μg/mL.
Beauvericin, a cyclic hexadepsipeptide isolated from Beaveria bassiana, is toxic to shrimps and is a moderate inhibitor of Grampositive bacteria, fungi, and mosquito larvae [1] . Other analogues were isolated with different bioactivities, such as mosquito larvae toxic beauvericins A and B from B. bassiana [2] , beauvericin D  F from a Beauveria sp. strain acting as a potentiator for fluconazole against fluconazole-resistant Candida albicans [3, 4] , cytotoxic beauvericins from Cordyceps cicadae [5] and cytotoxic, antimalarial and anti-tubercular beauvericin analogues [6] . During our systematic search for new bioactive compounds from marinederived microbes isolated from the sediment of the Bohai Sea, a new beauvericin analogue, named as beauvericin K (1), together with beauvericin D (2) and beauvericin (3) (Figure 1 ), were identified from a strain of Fusarium sp. CUGB-F011. Herein, we report the isolation, structure elucidation and bioactivity evaluation of the new compound.
Compound 1 was obtained as a colorless amorphous powder. The positive ESIMS of 1 gave a pseudo molecular ion peak cluster at 750.4 [M + H] + . The molecular formula was determined to be C 42 H 59 N 3 O 9 by analysis of its HRESIMS (m/z 772.4149 [M + Na] + ). The 1 H NMR spectrum of 1 showed ten protons for two monosubstituted phenyls at δ 7.14 -7.31, three N-methyl singlets at δ 3.07 (3H, s, H 3 -36), 3.04 (3H, s, H 3 -21) and 3.00 (3H, s, H 3 -6), and eight methyl doublets at 0.95 (3H, d, J = 6.6 Hz, H 3 -34), 0.91 (3H, d, J = 6.6 Hz, H 3 -41), 0.86 (3H, d, J = 6.6 Hz, H 3 -33), 0.82 (3H, d, J = 6.6 Hz, H 3 -40), 0.77 (3H, d, J = 6.6 Hz, H 3 -19), 0.75 (3H, d, J = 6.6 Hz, H 3 -4), 0.24 (3H, d, J = 6.6 Hz, H 3 -18), and 0.20 (3H, d, J = 6.6 Hz, H 3 -3). The 13 C NMR, HSQC and COSY data for 1 revealed 41 carbon signals associated with two mono substituted phenyls, four isopropyls, three methyls, three methylenes, three methines attached to oxygen, three methines attached to nitrogen, and six carbonyls. Three 2-hydroxyisovaleric acids (Hiv-1, Hiv-2 and Hiv-3) were identified by the corresponding COSY signals in bold as shown in Figure 2 Therefore, the structure was elucidated as shown in Figure 1 . The structures of 2 and 3 were identified as beauverincin D [4] and beauvericin [2] by comparison of their NMR spectroscopic data and optical rotations. From the biosynthesis point of view, the absolute configuration of 1 was characterized as being the same as that of beauvericin. All the isolated compounds showed significant inhibitory activities against Candida albicans with MIC values of 6.25 µg/mL; the MIC of the positive control, fluconazole, was 3.12 µg/mL. Anti-fungal assay: The antifungal activity was tested according to our previous report [7] .
Supplementary data: 1 H and 13 C NMR, 1 H-1 H COSY, HSQC, HMBC and ROESY spectra of the new compound 1.
